Mineralys Therapeutics, Inc. MLYS
- lorundrostat — Hypertension NDA Submitted
- lorundrostat — Chronic Kidney Disease Phase 2
- lorundrostat — Obstructive Sleep Apnea Phase 2
CYP11B2 (1 companies · 3 programs)
Companies with an active program directed at CYP11B2.